Rhabdomyosarcoma with bone marrow infiltration mimicking hematologic neoplasia

Biljana Jelić-Puskarić1, Koraljka Rajković-Molek, Ljubica Raić

  • 1Department of Medicine, Laboratory for Cytology and Hematology, "Merkur" University Hospital, Zagreb, Croatia. biljana.jelic.puskaric@zg.t-com.hr

Collegium Antropologicum
|August 12, 2010
PubMed

Insights

Rhabdomyosarcoma (RMS), a rare childhood cancer, can present unusually with bone marrow infiltration mimicking blood cancers. Early diagnosis using advanced techniques is crucial for effective treatment of this soft tissue sarcoma.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Pathology

Background:

  • Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma, typically presenting as a localized tumor.
  • Unusual presentations, such as bone marrow infiltration mimicking hematologic neoplasms, are rare but significant.
  • This case highlights a 14-year-old girl with initial symptoms suggesting a blood disorder.

Observation:

  • A 14-year-old girl presented with fatigue, bruising, leukocytosis, anemia, and thrombocytopenia.
  • Physical exam revealed petechiae, hematomas, lymphadenopathy, and splenomegaly.
  • Bone marrow aspiration showed undifferentiated tumor cells, suppressing normal blood cell production.

Findings:

  • Cytologic and biopsy findings confirmed alveolar subtype of Rhabdomyosarcoma.
  • A large retroperitoneal primary tumor was identified via CT scan.
  • The patient's presentation mimicked a hematologic malignancy due to bone marrow infiltration.

Implications:

  • Rhabdomyosarcoma should be considered in the differential diagnosis of pediatric bone marrow infiltration.
  • Advanced diagnostic techniques like immunocytochemistry and flow cytometry are vital for accurate RMS diagnosis.
  • Timely diagnosis of rare RMS presentations is essential for appropriate management and improved outcomes.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...